BSEInsider Trading / SAST26 Sept 2026 · 26 Sept 2026, 07:37 pm

Intimation of Closure of Trading Window

Bacil Pharma Ltd · 524516

✦ AI Summary

Bacil Pharma Ltd has announced the closure of its trading window for the quarter and half year ended 30th September 2026, effective from 1st October 2026, until 48 hours after the conclusion of the Board of Directors meeting to consider the unaudited financial results.

Analysis Scores

Earnings Impact5/10
Growth Catalyst5/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Bacil Pharma Ltd - 524516 - Closure of Trading Window

Attachments (1)

📄

5f85d8ef-1645-43aa-8635-5759f169c7ef.pdf

pdf

Download →
View document text
Date: 26th September, 2026 BSE Limited Asst. General Manager, Department of Corporate Relations, P.J, Towers, Dalal Street, Fort, Mumbai- 400001. Scrip Code: 524516 Sub.: Intimation for Trading Window Closure for the quarter and half year ended 30th September 2026. Dear Sir, This is to inform that The trading window for the purpose of trading in the Shares of the Company by Designated Persons of the Company framed in accordance with SEBI (Prohibition of Insider Trading) Regulations, 2015 as amended from time to time, will remain close from 1st October, 2026 till 48 hours after the conclusion of the Meeting of the Board of Directors to be held for the purpose of considering the Un-audited Financial Results for the quarter and half year ended 30th September, 2026. The date of the Board Meeting for the aforesaid purpose shall be intimated to Stock exchange separately. Kindly take the same on record. Thanking you Yours Faithfully, For Bacil Pharma Limited Ms. Chaitali Kalpataru Shah Director DIN: 11167778